We have previously shown that treatment of mice with anti-CD4 (mAb clone GK1.5) on days 4 and 10 of B16 melanoma tumor growth induces priming of a protective CD8 T cell response against melanoma differentiation antigens, as a result of CD4+CD25+ Treg depletion [2]. The gene discussed is CD4; the disease is melanoma.